Slaugh John-David, Issa Meltiady, Grimm Eric, Calderon Antonio J, Sindelar Solomon, Van Hook Reed, McBeth Lauren, Maw Anna
Internal Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA.
Hospital Internal Medicine, Mayo Clinic, Rochester, USA.
Cureus. 2024 Sep 20;16(9):e69796. doi: 10.7759/cureus.69796. eCollection 2024 Sep.
Background Point-of-care lung ultrasound (LUS) is a guideline-recommended imaging modality that has been shown to be more accurate than chest radiography for multiple causes of dyspnea. This study was conducted to understand the impact of LUS on real-world clinical decision-making among hospitalists. Methods A retrospective chart review was conducted of patients who received a LUS while hospitalized at a quaternary care academic medical center between July 2020 and June 2022. Data was extracted from the electronic health record (EHR) into a standardized REDCap form. Cases were defined as patients who had received a LUS that (1) had images archived and accessible to viewing through the EHR and (2) had an imaging report documented in the EHR. Results Of the 820 LUSs reviewed, 297 (36.2%) were performed to evaluate for appropriateness of thoracentesis, 205 (25%) for diagnosing or monitoring of pneumonia related to COVID-19, 169 (20.6%) for volume status assessment, 136 (16.6%) for worsening respiratory status, 114 (13.9%) for monitoring pleural effusions, 64 (7.8%) for diagnosing or monitoring of pneumonia not related to COVID-19, and 12 (1.5%) for monitoring of diuresis. Documentation was sufficient to determine clinical decision-making in 730 (89%) of LUSs reviewed, 739 (90.1%) were considered to be diagnostically useful, and 327 (39.9%) changed management. Conclusions These findings suggest LUS was diagnostically useful and routinely changed management in hospitalist practice. Further, documentation in the EHR was sufficient to allow for the evaluation of real-world clinical decision-making using LUS, which is an important gap in both the education and health services research literature.
即时床旁肺部超声(LUS)是一种指南推荐的成像方式,已被证明在诊断多种原因导致的呼吸困难方面比胸部X光更准确。本研究旨在了解LUS对住院医师实际临床决策的影响。方法:对2020年7月至2022年6月期间在一家四级医疗学术中心住院时接受LUS检查的患者进行回顾性病历审查。数据从电子健康记录(EHR)中提取到标准化的REDCap表格中。病例定义为接受LUS检查的患者,这些患者满足以下条件:(1)有存档图像且可通过EHR查看;(2)EHR中有成像报告记录。结果:在审查的820例LUS检查中,297例(36.2%)用于评估胸腔穿刺的适宜性,205例(25%)用于诊断或监测与COVID-19相关的肺炎,169例(20.6%)用于评估容量状态,136例(16.6%)用于评估呼吸状况恶化,114例(13.9%)用于监测胸腔积液,64例(7.8%)用于诊断或监测与COVID-19无关的肺炎,12例(1.5%)用于监测利尿情况。在审查的730例(89%)LUS检查中,文档足以确定临床决策,739例(90.1%)被认为具有诊断价值,327例(39.9%)改变了治疗方案。结论:这些发现表明,LUS在住院医师实践中具有诊断价值且常规改变治疗方案。此外,EHR中的文档足以评估使用LUS的实际临床决策,这在教育和卫生服务研究文献中都是一个重要的空白。